Cita APA

Toumi, M., & Jadot, G. (2014). Economic impact of new active substance status on EU payers’ budgets: Example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis. J Mark Access Health Policy.

Chicago Style Citation

Toumi, Mondher, i Guy Jadot. "Economic Impact of New Active Substance Status On EU Payers’ Budgets: Example of Dimethyl Fumarate (Tecfidera(®)) for Multiple Sclerosis." J Mark Access Health Policy 2014.

Cita MLA

Toumi, Mondher, i Guy Jadot. "Economic Impact of New Active Substance Status On EU Payers’ Budgets: Example of Dimethyl Fumarate (Tecfidera(®)) for Multiple Sclerosis." J Mark Access Health Policy 2014.